Abiopharma

🔍 DOYLE THOMAS JAMES (Executive)

Company: Kura Oncology, Inc. (KURA)

Report Date: 2026-01-27

Detailed Transactions and Holdings:

• Sold 2,226 shares of Common Stock at $8.4607 per share (Direct)
  Date: 2026-01-27 | Code: S | equity_swap_involved: false | shares_owned_after: 150,083.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,114 shares of Common Stock at $8.4607 per share (Direct)
  Date: 2026-01-27 | Code: S | equity_swap_involved: false | shares_owned_after: 148,969.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 695 shares of Common Stock at $8.4607 per share (Direct)
  Date: 2026-01-27 | Code: S | equity_swap_involved: false | shares_owned_after: 148,274.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 2,226 shares of Common Stock at $8.4607 per share (Direct)
  Date: 2026-01-27 | Code: S | equity_swap_involved: false | shares_owned_after: 146,048.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 881 shares of Common Stock at $8.4607 per share (Direct)
  Date: 2026-01-27 | Code: S | equity_swap_involved: false | shares_owned_after: 145,167.00 | transaction_form_type: 4 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-27 | Code: H | nature_of_ownership: spouse's 401(k) | shares_owned_after: 500.00

Footnotes:

• F1: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.
• F2: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.
• F3: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
• F4: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25.
• F5: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22.